Arete Wealth Advisors LLC purchased a new position in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 6,500 shares of the company's stock, valued at approximately $314,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in TEM. Cherry Tree Wealth Management LLC purchased a new stake in Tempus AI in the first quarter worth $31,000. University of Texas Texas AM Investment Management Co. purchased a new stake in Tempus AI in the first quarter worth $33,000. Continuum Advisory LLC purchased a new stake in Tempus AI in the first quarter worth $39,000. Bartlett & CO. Wealth Management LLC lifted its stake in Tempus AI by 100.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock worth $39,000 after acquiring an additional 400 shares during the period. Finally, Nemes Rush Group LLC purchased a new stake in Tempus AI in the first quarter worth $39,000. Hedge funds and other institutional investors own 24.22% of the company's stock.
Analysts Set New Price Targets
A number of analysts recently commented on TEM shares. Guggenheim raised their price target on Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research note on Monday, June 30th. BTIG Research raised their price objective on Tempus AI from $75.00 to $85.00 and gave the company a "buy" rating in a research report on Wednesday, August 20th. Piper Sandler reissued a "neutral" rating on shares of Tempus AI in a research report on Friday, August 8th. HC Wainwright raised their price objective on Tempus AI from $90.00 to $98.00 and gave the company a "buy" rating in a research report on Friday. Finally, Morgan Stanley raised their price objective on Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a research report on Tuesday, August 12th. Seven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $70.17.
View Our Latest Analysis on Tempus AI
Tempus AI Price Performance
NASDAQ TEM traded down $2.40 during trading hours on Friday, hitting $86.38. The company's stock had a trading volume of 6,728,445 shares, compared to its average volume of 10,232,446. Tempus AI, Inc. has a 12 month low of $31.36 and a 12 month high of $91.45. The company's 50 day simple moving average is $67.61 and its two-hundred day simple moving average is $59.61. The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.43.
Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings data on Friday, August 8th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company had revenue of $314.64 million during the quarter, compared to the consensus estimate of $296.84 million. During the same period last year, the company earned ($6.86) EPS. Tempus AI's revenue for the quarter was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. Equities research analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, CEO Eric P. Lefkofsky sold 332,500 shares of Tempus AI stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $74.10, for a total value of $24,638,250.00. Following the completion of the sale, the chief executive officer directly owned 9,207,533 shares in the company, valued at approximately $682,278,195.30. This trade represents a 3.49% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Andrew Polovin sold 5,398 shares of Tempus AI stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $402,960.70. Following the completion of the sale, the executive vice president owned 132,056 shares of the company's stock, valued at $9,857,980.40. The trade was a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 903,104 shares of company stock worth $63,733,330 in the last three months. 26.27% of the stock is currently owned by company insiders.
About Tempus AI
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
See Also
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
